Concerta

Attention Deficit Hyperactivity Disorder (ADHD)

Concerta is primarily prescribed to manage the symptoms of ADHD. It is an extended-release formulation of methylphenidate, designed to release the medication gradually throughout the day. It is used to help:

• Increase the ability to pay attention and stay focused.
• Decrease impulsiveness and hyperactive behavior.
• Improve organization and listening skills.

Comprehensive Treatment Plans

This medication is typically used as one part of a total treatment program for ADHD. Healthcare providers often prescribe it alongside other non-drug therapies, which may include:

• Psychological or behavioral counseling
• Educational interventions
• Social therapy

Concerta is approved for use in children 6 years of age and older, adolescents, and adults up to age 65. It is not recommended for use in children under the age of 6.

Mechanism of Action

Concerta belongs to a class of medications known as stimulants. It works by increasing the activity of two specific neurotransmitters in the brain: dopamine and norepinephrine. These chemicals are naturally occurring substances that help transmit signals between nerve cells and play a key role in regulating attention and behavior.

By boosting the availability of these neurotransmitters, Concerta helps to:

• Improve attention span and the ability to focus.
• Reduce impulsivity and hyperactivity.
• Help individuals stay organized and follow through on tasks.

Extended-Release Delivery

Concerta is an extended-release tablet designed to provide a steady effect throughout the day. It uses a specialized osmotic delivery system to release the medication at a controlled rate. When the tablet is swallowed, the outer coating dissolves quickly to provide an initial dose of methylphenidate.

The remaining medication is contained inside the tablet and is gradually released as the tablet absorbs moisture in the digestive tract. This process allows the medication to work for approximately 12 hours, which helps maintain consistent symptom control and reduces the need for multiple doses during the day.

Common Side Effects

Many people using Concerta experience mild side effects as their body adjusts to the medication. Common issues include:

• Nervousness or anxiety
• Difficulty falling asleep or staying asleep
• Loss of appetite and weight loss
• Stomach pain, nausea, or vomiting
• Dry mouth
• Dizziness
• Headache
• Increased sweating
• Irritability or mood swings

Serious Side Effects

While less common, some side effects can be severe. Seek medical help right away for any of the following:

• Heart-related symptoms: Chest pain, shortness of breath, or fainting.
• Psychiatric symptoms: Seeing or hearing things that are not real, believing things that are not true, or unusual suspiciousness.
• Circulation problems: Numbness, pain, or skin color changes (such as turning pale, blue, or red) in the fingers or toes.
• Priapism: A painful or prolonged erection lasting more than four hours.
• Neurological issues: Seizures or new muscle tics and twitches.
• Vision changes: Blurred vision or other changes in eyesight.

Abuse and Dependence

Concerta is classified as a controlled substance because it has a high potential for abuse and may lead to dependence. Healthcare providers typically assess the risk of abuse before prescribing and monitor for signs of misuse or addiction during treatment.

Cardiovascular Risks

Serious heart-related problems have been reported with the use of stimulant medications, including:

• Sudden death: This risk is primarily associated with patients who have structural heart abnormalities or other serious heart conditions.
• Stroke and heart attack: These events have been reported in adults taking stimulant medications.
• Blood pressure and heart rate: Concerta can cause increases in blood pressure and heart rate. Regular monitoring is often recommended, especially for those with pre-existing hypertension or heart conditions.

Psychiatric Warnings

Stimulant medications may cause or worsen certain mental health symptoms:

• Psychotic or manic symptoms: New symptoms such as hallucinations, delusional thinking, or mania may occur in children and teenagers who have no prior history of these issues.
• Aggression: Increased hostility or aggressive behavior has been observed in some patients starting treatment for ADHD.
• Pre-existing conditions: The medication may worsen symptoms of behavior and thought disturbances in patients with a pre-existing psychotic disorder or bipolar disorder.

Contraindications

Concerta is generally not recommended for individuals with certain medical histories, including:

• Glaucoma.
• A personal or family history of motor tics or Tourette's syndrome.
• Severe anxiety, tension, or agitation.
• Recent use of a monoamine oxidase inhibitor (MAOI) within the past 14 days, as this can lead to a hypertensive crisis.

Other Precautions

Priapism: Prolonged and sometimes painful erections have been reported with methylphenidate products. This condition requires immediate medical attention to prevent permanent damage.

Circulation Problems: Some patients experience peripheral vasculopathy, including Raynaud's phenomenon. Symptoms may include numbness, pain, or color changes (from pale to blue to red) in the fingers or toes.

Growth Suppression: Long-term use of stimulants in children may lead to a slowing of growth in both height and weight. Healthcare providers typically monitor a child's growth progress during treatment.

Gastrointestinal Narrowing: Because the Concerta tablet is non-deformable and does not change shape in the digestive tract, it is typically avoided in patients with severe narrowing of the esophagus, stomach, or intestines.

Generic Equivalence: The FDA has noted that certain generic versions of methylphenidate hydrochloride extended-release tablets may not be therapeutically equivalent to the brand-name product because they may release the medication into the body at a different rate.

Pregnancy

The safety of using Concerta during pregnancy has not been fully established due to a lack of comprehensive studies in humans. Animal studies have indicated potential risks to the fetus when the drug is administered at high doses, but these results do not always predict human outcomes. It is generally recommended that Concerta be used during pregnancy only if the potential benefit to the mother outweighs the potential risk to the developing baby.

Breastfeeding

Methylphenidate, the active ingredient in Concerta, passes into breast milk in small quantities. While there is limited information on how this affects nursing infants, healthcare providers suggest monitoring the baby closely for any unusual symptoms. Signs to watch for include:

• Increased agitation or irritability
• Changes in sleep patterns
• Difficulty with feeding or weight gain

Individuals who are pregnant, planning to become pregnant, or breastfeeding should discuss their treatment plan with a healthcare provider to determine the safest course of action for their specific situation.

Dosage Forms

Concerta is provided in the following form:

• Extended-release tablet: This is an oral tablet designed to release the medication gradually throughout the day.

The tablet uses a specialized delivery system that requires it to be swallowed whole with liquids. It should not be crushed, chewed, or divided, as this would destroy the controlled-release properties of the medication and release the drug too quickly.

FDA Approval and Indications

Concerta (methylphenidate hydrochloride) is FDA-approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6 to 12, adolescents, and adults up to age 65.

Boxed Warning

The FDA has issued a boxed warning for Concerta due to its high potential for abuse and dependence. Healthcare providers are advised to assess the risk of abuse before prescribing the medication and to monitor patients for signs of misuse or addiction during treatment.

Controlled Substance Status

Concerta is classified by the Drug Enforcement Administration (DEA) as a Schedule II controlled substance. This classification is reserved for drugs that have a high potential for abuse, which may lead to severe psychological or physical dependence.

Generic Equivalence and Safety Communications

The FDA has issued specific communications regarding the therapeutic equivalence of certain generic versions of Concerta. The agency changed the therapeutic equivalence rating for generic methylphenidate hydrochloride extended-release tablets manufactured by Mallinckrodt and Kudco (now Lannett). The FDA determined these specific generics might not provide the same therapeutic effect over a 12-hour period as the brand-name drug because they do not use the same specialized delivery system.

Additionally, the FDA has conducted safety reviews regarding the use of stimulant medications for ADHD and their impact on cardiovascular health. While monitoring continues, the FDA maintains that these medications are safe and effective when used according to the approved labeling.

Withdrawal Symptoms

If Concerta is stopped abruptly after being used for a long period or at high doses, withdrawal symptoms may occur. This is sometimes referred to as a stimulant crash. Common symptoms of withdrawal include:

• Extreme tiredness or fatigue
• Depression or low mood
• Sleep problems, such as insomnia
• Increased appetite
• Irritability or agitation

Managing Discontinuation

Because of the risk of withdrawal, it is important not to stop taking Concerta without consulting a healthcare professional. A doctor will typically provide a schedule to gradually taper the dose, which helps the body adjust and reduces the severity of symptoms. If you experience severe depression or suicidal thoughts while stopping the medication, seek medical attention immediately.